Close
Nordic 9Nordic 9

Mybacs (private company)

Switzerland mybacs.com
See something wrong or missing? Let us know
Offices:Zug
Industry:BiotechHealth servicesPharma
Business model:B2B

Mybacs is a Swiss biotechnology company specialized in the human microbiome, namely around intestinal healthcare and improving the daily well-being of their customers.

Investors: we tracked 7 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 5.99M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Mybacs

Name Criteria
Denmark Octarine Bio
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Netherlands InnoSIGN
70%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
France PEP-Therapy
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Sweden Oncorena
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Switzerland Resistell
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Metrion Biosciences
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Netherlands Matisse Pharmaceuticals
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Carcinotech
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
France AbolerIS Pharma
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 2
Denmark Acesion Pharma
65%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 4
  • At least one other investor: found 2
Top